Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-05-31
DOI
10.1186/1471-2407-12-192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
- (2011) Roberta Mazzieri et al. CANCER CELL
- Methylselenocysteine – a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs
- (2011) Arup Bhattacharya Expert Opinion on Drug Delivery
- Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer
- (2011) Indu Sinha et al. INTERNATIONAL JOURNAL OF CANCER
- Mouse Prostate Proteomes Are Differentially Altered by Supranutritional Intake of Four Selenium Compounds
- (2011) Jinhui Zhang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
- (2011) Pipsa Saharinen et al. TRENDS IN MOLECULAR MEDICINE
- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
- (2010) H. Hashizume et al. CANCER RESEARCH
- Selenium and the Thyroid: A Close-Knit Connection
- (2010) Leonidas H. Duntas JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
- (2010) J. L. Brown et al. MOLECULAR CANCER THERAPEUTICS
- O papel das selenoproteínas no câncer
- (2010) Kaluce Gonçalves de Sousa Almondes et al. Revista da Associacao Medica Brasileira
- Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas
- (2010) Gelareh Zadeh et al. Journal of Oncology
- Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
- (2009) Beverly L. Falcón et al. AMERICAN JOURNAL OF PATHOLOGY
- The role of the Angiopoietins in vascular morphogenesis
- (2009) Markus Thomas et al. ANGIOGENESIS
- Selenium and thyroid
- (2009) Josef Köhrle et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit
- (2009) L. Wang et al. Cancer Prevention Research
- Inhibition of Colon Cancer Growth by Methylselenocysteine-Induced Angiogenic Chemomodulation Is Influenced by Histologic Characteristics of the Tumor
- (2009) Arup Bhattacharya et al. Clinical Colorectal Cancer
- Tumor Vascular Maturation and Improved Drug Delivery Induced by Methylselenocysteine Leads to Therapeutic Synergy with Anticancer Drugs
- (2008) A. Bhattacharya et al. CLINICAL CANCER RESEARCH
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
- (2008) Scott M. Lippman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio
- (2008) Shannon Reagan-Shaw et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now